Peng Zhang is currently an Associate Director in Integrated Evidence Generation at Bayer Pharmaceuticals. They have a Master of Surgery in Urologic Oncology and a Bachelor of Clinical Medicine from Central South University. Peng started their career in clinical research at药明康德 and has extensive experience in oncology and pulmonary hypertension, serving as a Medical Advisor for antibiotics and leading clinical development for prostate cancer products. Since August 2018, they have been the Country Medical Expert for Oncology at Bayer, having previously held roles including Medical Advisor Manager for Avelox and Sivextro.
This person is not in any teams
This person is not in any offices